Building on our previous study, the present study innovatively developed a DR risk prediction model that integrates five key variables: Neutrophil, 25(OH)D3, Duration of T2DM, HbA1c and ApoA1. This evidence concerns the gene APOA1 and type 2 diabetes mellitus.